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De todos os catiões presentes no corpo, o magnésio é o segundo mais importante 
catião e o quarto mais prevalente. Doenças que envolvem o magnésio são classificadas 
em dois grupos: hipomagnesemia (défice de magnésio) e hipermagnesemia. Desta 
forma, a determinação de magnésio despertou grande interesse, porque auxilia no 
contexto clínico e em pesquisas epidemiológicas.  
Portanto, o objetivo deste trabalho foi desenvolver um dispositivo microfluídico  
analítico em papel (µPAD) para quantificar magnésio em amostras salivares.  
Neste caso em concreto, o µPAD baseia-se numa reação colorimétrica entre o 
magnésio e o eriocrómio de cianina, formando uma cor laranja/avermelhada intensa. 
Após a reação, é necessário utilizar um scanner de mesa para obter uma imagem de alta 
resolução da zona de deteção do µPAD para determinar a intensidade de cor laranja/ 
avermelhada de cada unidade de teste, medida através do software Image J.  
Sob condições ótimas, o método para o µPAD proposto foi caracterizado por um 
intervalo de calibração para a concentração de magnésio entre 0.082 – 0.247 mmol/L. 
Os limites de deteção e quantificação foram 0.062 mM e 0.081 mM, respetivamente. O 
gasto dos reagentes, eriocrómio cianina, NH4Cl e NH4OH foram 0.043 mg, 1.62 mg e 
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Of all the cations in the body, magnesium is the second most important 
intracellular cation and the fourth most prevalent. Disorders involving magnesium are 
categorized into two groups: hypomagnesemia (magnesium deficiency) and 
hypermagnesemia. In this way, the determination of magnesium has aroused great 
interest, because it helps in the clinical context and epidemiological research. 
Therefore, the objective of this work was to develop a microfluidic paper-based 
analytical device (µPAD) for the quantification of magnesium in saliva samples.  
In this case, the µPAD is based on the colorimetric reaction between magnesium 
and eriochrome cyanine to form an intense orange/reddish dye. After the reaction, it is 
necessary to use a flatbed scanner to obtain a high-resolution image of the detection 
zone for determination the intensity of the orange/reddish colour within each detection 
zone measured with Image J software. 
Under the optimum conditions, the proposed µPAD method was characterized by a  
linear calibration range for magnesium concentration 0.082 – 0.247 mmol/L. The 
detection and quantification limits were 0.062 mM and 0.081 mM, respectively. The 
reagents, eriochrome cyanine, NH4Cl and NH4OH consumption were 0.043 mg, 1.62 
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1. INTRODUCTION  
 
1.1.  Saliva  
In most laboratory diagnostic procedures, blood is the most commonly used 
sample type because of its cellular and chemical constituents, and because it reflects the 
real concentration of the various analytes [1]. However, in recent years, there has been 
an increasing need to study alternative blood plasma samples, as this type of sampling is 
done invasively and has associated risk potentials such as infections and bruises. Some 
of these alternatives can be another type of biological fluid, such as sweat, urine and 
saliva [2]. When compared to the other alternatives, saliva is easily accessible, can be 
collected non-invasively and without violating patient privacy [3]. Saliva, due to its 
various constituents (e.g., biological material, proteins and microorganisms), has 
become a type of clinical interest sampling and has been implemented in multiple 
diagnostic tests for monitoring health conditions and certain diseases [4]. 
 
1.1.1. Salivary production, composition and functions  
Saliva belongs to a large group of mucous fluids (e.g. tear fluid, nasal mucus, 
cervical mucus, etc.) and plays a critical role in the physiology of the organism [5]. 
Saliva is the fluid present in the oral cavity and is mainly produced by three salivary 
glands: parotid, submandibular and sublingual (Figure 1.1), and a large number of 
smaller salivary glands [6]. However, the whole saliva also comes from the non-
glandular origin as it is composed of a complex mixture of fluids from other regions, 
such gingival fold fluids, oral mucosal transudate and mucus of the nasal cavity 
(bacteria, fungi, virus, upper airways secretions). Besides, oral fluid may also contain 







Figure 1.6 - Salivary glands and respective % of saliva production for unstimulated salivary flow [8]. 
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The salivary liquid is mostly composed of water (about 99%). However, it is 
also comprised of inorganic compounds (e.g. ionic compounds), organic compounds 
(e.g. uric acid, glucose), protein/polypeptide compounds (e.g. amylase, albumin) and 
hormones (e.g. steroids) [9][10]. Saliva contains a variety of electrolytes (Table 1.1), the 
most abundant of which are sodium, potassium, chloride and bicarbonate. Calcium, 
magnesium and phosphate are present in lower concentrations [7][11].  
 
Table 1.6 - Electrolyte and total protein concentrations in whole human oral fluid and plasma [7]. 
 Plasma Whole human resting oral fluid 
Whole human stimulated 
oral fluid 
Na+ (mmol/L) 145 5 20-80 
K+ (mmol/L) 4 22 20 
Ca2+ (mmol/L) 2.2 1-4 1-4 
Cl- (mmol/L) 120 15 30-100 
HCO3- (mmol/L) 25 5 15-80 
Phosphate (mmol/L) 1.2 6 4 
Mg2+ (mmol/L) 1.2 0.2 0.2 
SCN- (mmol/L) <0.2 2.5 2 
NH3 (mmol/L) 0.05 6 3 
(NH2)2CO (mmol/L) 2-7 3.3 2-4 
Protein (g/L) 70 3 3 
 
 
Under healthy conditions, adults usually produce about 0.5 to 1.5 L of saliva per 
day, at a rate between 0 mL/min (during sleep) to 5 mL/min (during chewing or in the 
presence of stimuli). Total salivary flow can be classified as normal (1.0 - 4.0 mL/min), 
low (0.7 - 1.0 mL/min) and very low (< 0.7 mL/min) [12]. However, as salivary flow 
shows great biological variation, the composition (qualitatively) and the volume 
produced (quantitatively) are not only influenced by the time of day, but also due to 
various physiological and pathological conditions. Thus, salivary flow (SF) can be 
called stimulated and unstimulated SF [8]. Stimulated salivary flow represents saliva 
produced in the presence of mechanical, taste, olfactory or pharmacological stimuli, 
contributing about 80-90% of total salivary production. In addition to the presence of 
stimuli, saliva volume and composition may be influenced by factors such as hormonal 
changes (e.g. pregnancy), alcoholism and smoking, age, physical exercise, body weight, 
hereditary influences, and mouth hygiene. Unstimulated saliva represents a small 
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continuous salivary flow, called basal secretion, whose role is to moisturize and 
lubricate oral tissues continuously [13]. 
Saliva is one of the most complex and vital body fluids for preserving oral tissue 
health and for a variety of physiological needs. This oral fluid plays a crucial role in 
preliminary digestion as it softens foods and assists in the preparation, chewing, 
digestion and swallowing of the bolus. Also, it protects tissues from mechanical damage 
by cleaning up the debris present in the oral cavity and also protects tissues from 
irritants agents such as bacteria, virus and fungi. Due to its composition, it also plays an 
essential role in maintaining mineralization of tooth enamel. Other important saliva 
functions include its role in speech, taste, ability to buffer acidic foods and antibacterial, 
breath odour control while maintaining the integrity of the oral and gastrointestinal 
mucosa [8][14]. 
 
1.1.2. Historic of salivary analysis and clinical applications   
In recent years, several studies have been developed to assess and monitor health 
status to implement surveillance diagnoses of human health through saliva analysis. 
Surprisingly, however, saliva has been used in clinical diagnostics for over 2000 years. 
For ancient practitioners of traditional Chinese medicine, saliva and blood are “sister 
fluids” from the same origin, and changes in oral fluid are indicative of the wellness of 
the individual (e.g. viscosity, odour, taste, etc.). Theories such as excessive saliva 
secretion are related to heartburn or sweet-tasting saliva related to problems with spleen 
functioning were some of the historical hallmarks of early saliva applications for health 
monitoring [15]. 
The use of this type of sampling has been a bet in several studies and, in most of 
them, aimed to implement in the routine medical practice component. Demand to 
develop tests based on salivary specimens rather than using blood specimens has been 
quite high since specimen collection has no associated risk potential and can be 
achieved very affordably [16]. However, the biggest challenge associated with testing 
has been the discovery and hence, validation of salivary biomarkers for certain diseases 
[17].   
In recent years, there have been several successful oral fluid-based diagnostic 
tests (Table 1.2), such as saliva-based tests for the detection of HIV antibodies, with 
high specificity and sensitivity similar to blood tests. (Roberts KJ) Saliva-based tests to 
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predict premature birth (estradiol analysis), evaluate female reproductive cycles 
(estrogen, testosterone and electrolyte analysis) and assess stress level (cortisol analysis) 
[16]. Saliva has also been widely used in dentistry for oral disease studies to avoid the 
risk of tooth decay by measuring saliva buffer capacity and assessing bacterial content 
[18].   
There have been several study proposals for saliva research, namely, viral and 
bacterial infections (genomes and antibodies detection), cancer, pharmaceutical and 
abuse drugs, hormones, DNA tests (using oral cells), sialo chemistry analysis, etc. [6]. 
Besides, the importance of using saliva is not only useful in clinical practice for 
diagnosing disease but has also been increasingly used in law enforcement agencies to 
develop methods for detecting illegal poisoning [2].  
 
Table 1.7 - Current and potential use of saliva based diagnostics [18]. 
Current existing assays with active development of new 
detection systems 
Potential use in near future 
Pharmacological monitoring 
Therapeutic drugs 
Law enforcement applications  
     Drug intoxication  
     Illicit drugs  
     Forensics 
Smoking exposure cotinine and thiocyanate  
Steroid hormones  
Cortisol, estrogen, testosterone and progesterone  
Infectious diseases  
      Antibody testing: HIV, HCV and HBV 
     Antigen detection: bacterial, viral, fungal DNA/RNA/Protein 
     Microorganism recovery: bacterial, viral, fungal cultures 
Autoimmune diseases 
     Allergic markers  
Cardiovascular diseases  
     Acute myocardial infarction 
     Cardiac risk 
Cancer screening and diagnosis 
     Oral cancer 
     Breast cancer  
     Cancer-specific markers  
Periodontal diseases  
 
1.1.3. Advantages and disadvantages of saliva samples  
In recent years, there is a growing interest in studying other biological fluids, 
with the same constituents as blood plasma, to develop clinical trials. Blood is 
considered the best body fluid for developing systemic processes, as it reflects the 
actual concentration of analytes. However, the methodology used to collect such 
samples is quite invasive and involves some potential risk for the patient, such as 
bruises, discomfort, possible site infections and anaemia. Besides, such samples are also 
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less favoured when research involves children or cases of difficult venous access 
(severe diseases and the elderly) [13]. 
For this, biological fluids such as urine, sweat and saliva have been excellent 
alternatives to replace blood samples, since their collection is non-invasive.  Urine 
allows the accumulated measurement of analytes. However, results are dependent on the 
patient's fluid intake, which may vary substantially. Urine specimen collection has 
contested as it aims to invade patient privacy in case of sampling supervision [7]. 
Unlike urine, saliva can be collected under supervision without any violation of 
privacy. In this case, the collection is simple, stress-free (procedure without needles), 
less discomfort, cheap and simple. Some advantages of using saliva as sampling are 
shown in Figure 1.2. These samples are relevant and useful if children and the elderly 
need to be evaluated or for large-scale screening, offering an economic approach [19]. 
Samples can be taken by patients themselves or by poorly trained people, and can even 
be applied to less-favoured areas or unconventional environments (e.g. developing 
countries) as it does not require very elaborate equipment [15]. 
 
Figure 1.7 - Schematic representation of the advantages of saliva specimen over other bio samples [2]. 
 
However, saliva collection has some disadvantages, such as the fact that, 
compared to blood samples, their volume is limited and salivary biomarkers are still 
mostly unknown. The fact that salivary flow varies, both in volume and composition, in 
the presence of stimulating factors, it should be emphasized that the results depend on 
the cooperation of the individual, that is, depending on the psychological status and 
whether they consumed medicines [16]. Also, there is a need for more sensitive 
quantification methods, which may be related to the fact that the salivary matrix is quite 
complex, making interpretation of the results difficult [19]. 
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1.1.4. Collection and sample storage  
As mentioned above, the stimulated salivary flow is dependent on the presence 
of stimuli, and consequently, their composition may be altered. Thus, unstimulated 
saliva collection generally correlates with clinical conditions more accurately than 
stimulated saliva. An essential requirement for collecting salivary samples is to 
minimize all possible sources of variation in salivary composition. The most traditional 
way to obtain this fluid is to place the patient sitting with the head bent forward and 
allow the saliva to drip from the mouth into a collection container passively. However, 
this procedure is not very comfortable for the patient. Another method for collecting 
saliva is to ask the patient to spit gently into a vial. However, spit samples have been 
shown to contain up to 14 times more bacteria than passive drool [1][20]. 
When the above procedures are not possible, the only alternative is to use 
materials to collect saliva more efficiently. However, by introducing the elements into 
the patient's mouth, it stimulates the production of saliva and consequently may change 
its composition. The collection can be done through specific devices (larger sample 
volume), use of sterile swabs (faster), pipet aspiration under the tongue, chewing a piece 
of standard size paraffin, among others. The purpose of the devices facilitates sample 
collection in young children who have difficulty spitting. When using sterile swabs, the 
patient should remain with the gauze in their mouth for a few minutes until saturated, 
and then taken to the centrifuge to collect the fluid [19]. Before the collection of saliva, 
the patient should be informed in advance of the importance of the collection protocol. 
Information such as: to exclude tooth brushing, samples should preferably be taken 
fasting or at least 2-3 hours without consuming food or medicine. For the same reason, 
patients should be advised to rinse their mouth thoroughly with deionized water before 
collection [2]. 
After the saliva collection, the most effective process is freezing the sample to 
maintain the integrity of its constituents. The choice of different storage procedures 
before analysing the samples depends on the type of analyte to be analysed. Freezing 
samples is generally the most appropriate procedure because it prevents the growth of 
microorganisms and the degradation of analytes. However, if the analysis is done 
immediately after collection (up to 90 minutes), samples can be stored at room 
temperature. If the analysis was done between 3h-6h after collection, the samples 
should be placed in a 4 °C refrigerator. If the analysis is done days or even months after 
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collection, specimens should be stored at -20 ° C or, depending on the analyte, at -80 °C 
[2] [21].  
 
1.1.5. Detection techniques to determine analytes  
Whole oral fluid compounds have been examined with a large number of 
techniques: colorimetric/spectrophotometric, gas chromatography (GC), ion 
chromatography (IC), high performance liquid chromatography (HPLC) and as atomic 
absorption spectroscopy (AAS) [4]. However, all of these methods require robust, 
expensive and bulky equipment, which must be operated by a qualified laboratory 
professional. Thus, the need arose to create new alternative analytical techniques that 
determine the same analytes, with similar detection sensitivity. Thus, the possibility of 
using microfluidic paper-based analytical devices as an alternative tool for the 
determination of analytes present in saliva was explored, due to the simplicity of the 







The determination of electrolytes in human fluids is one of the most important 
functions in the clinical laboratory. Electrolytes affect most metabolic processes and are 
therefore part of several studies in the field of clinical research [22].  
 
1.2.1. Overview of the analyte  
Of all the cations in the body, magnesium is the fourth most prevalent and the 
second most abundant intracellularly [23]. Magnesium plays an important physiological 
role in many body functions (Table 1.3). Is essential for the synthesis of nucleic acids 
and proteins, regulatory systems, replication and for specific actions in different organs 
(e.g. neuromuscular and cardiovascular systems). Physiologically, magnesium acts as a 





Table 1.8 - Physiological functions of magnesium [25]. 
Enzyme function 
  
Enzyme substrate (ATPmg, GTPmg) 
    Kinases B           Hexokinase 
                               Creatine kinase 
                               Protein kinase 
 
ATPases or GTPases  
                Na+, K+ -ATPase 
                Ca2+, ATPase 
 
 
Cyclases                
                Adenylate cyclase 
                Guamylate cyclase  
 
Direct enzyme activation  
    Phosphofructokinase 
    Creatine kinase  
    5-phosphoribosyl-pyrophosphate synthetase 
    Adenylate cyclase  
    Na+, K+ -ATPase 
 
Membrane function  
    Cell adhesion  
    Transmembrane electrolyte flux  
 
Calcium antagonist  
    Muscle contraction/relaxation  
    Neurotransmitter release 
    Action potential conduction in nodal tissue 
 
Structural function  
    Protein  
    Polyribosomes  
    Nucleic acids 
    Multiple enzyme complexes 




1.2.2. Magnesium metabolism  
The body of a healthy adult contains approximately 21-28 g of magnesium. 
About 60% of the magnesium is present in bones, 20% in skeletal muscle, 19% in other 
soft tissues and less than 1% in the extracellular fluid. Usually, the total serum 
magnesium concentrations range from 0.7 – 1.3 mmol/L. About 20% of serum 
magnesium concentrations is protein bound (e.g. albumin), 65% is free ionized 
magnesium and the rest is associated with complexed formed between magnesium and 
various anions (e.g. phosphate). The reference range for serum ionised magnesium 
concentrations ranges from 0.54 – 0.67 mmol/L [25]. 
Until then, there is not much information about the mechanisms involved in the 
regulation of intracellular magnesium. However, it is known that 0.5 – 5% of total 
cellular magnesium is free ionised magnesium. The remaining percentage is related to 
complexes formed between magnesium and other compounds such as ATP, proteins or 
DNA [25]. 
Magnesium concentrations in other biological fluids may have different 
values/ranges compared to blood samples. In salivary samples, the magnesium 
concentration is 0.2 mmol/L [7] [26]. In urine samples, values of less than 1.0 mmol/L 
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indicate that the patient needs supplementation. Yet, if the magnesium concentration 
was bellow 0.4 mmol/L indicate danger for the patient and may be an indicator of a 
disease [27].  
Magnesium balance in the body, like that of other ions, is assessed by the 
function between ingestion and urinary excretion. In adults, the daily intake of 
magnesium is on average, between 5.6 - 6.8 mg/kg of body weight. However, the 
recommended daily dose is 4.5 mg/kg of body weight [27]. 
To ensure normal magnesium levels in the body, it is necessary to eat certain 
foods with sufficient Mg content. The main dietary sources of magnesium are cereals, 
grains, green vegetables (e.g. spinach), nuts, fruits, vegetables and tubers (e.g. potatoes). 
Water can be an essential source of magnesium. In general, magnesium intake is 
directly related to energy intake, except when most energy is associated with refined 
sugars or alcohol [25]. 
 
1.2.3. Assessment of magnesium status  
Although the importance of magnesium is widely acknowledged, after several 
researches, there is still no simple, accurate and rapid laboratory test in clinical 
medicine, to determine total body magnesium status. To date, the serum magnesium 
concentration is the predominant test used by medicine to assess magnesium status [23].  
However, there are several places where magnesium can be stored and excreted 
so that the analyte can be measured.  Serum magnesium concentration can obtain 
through total magnesium, ultrafiltrate magnesium and ionized magnesium. If the status 
of Mg is to be measured by intracellular magnesium content, it can be obtained from red 
cells, mononuclear blood cells or skeletal muscle. The intracellular concentration of free 
magnesium is evaluate, using fluorescent dyes may be used, provided they form 
complexes with the analyte, or also by nuclear magnetic resonance spectroscopy. There 
are some methodologies, for assessing magnesium status, that are less widely used, 
namely using hair or teeth samples [25].  
 
 
1.2.4. Clinical significance and associated diseases 
Monitoring the free magnesium level of a patient is important in preventing life-
threatening complications that can occur depending on the analyte concentration levels. 
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Disorders involving magnesium are characterised in two groups: hypomagnesemia 
(magnesium deficiency) and hypermagnesemia [25]. 
Hypomagnesemia is not rare. Prevalence pf hypomagnesemia varies from 7% 
and 11% in hospital patients. By relating serum magnesium concentrations to hypo, it is 
possible to state that the body's magnesium concentration is below normal when Mg 
concentrations vary between 0.41 - 0.82 mmol/L. However, the patient is at risk if the 
Mg concentration is 0.41 mmol/L or less. Causes of hypomagnesaemia and magnesium 
deficiency are listed in the Table 1.4. The magnesium loss can occur through vomiting 
or nasogastric suction. However, its occurrence is usually due to magnesium wasting in 
the gastrointestinal tract (diarrheal). An example of the effects of magnesium 
deficiency, causing serious complications in patient care, is a cardiac arrhythmia. These 
deficiencies can be quickly treated with parenteral magnesium or oral administration in 
more mild cases [28]. 
Magnesium deficiency is usually a consequence of certain diseases or drugs. 
Chronic renal failure occurs due to a loss of magnesium [29]. Very low magnesium 
concentrations are commonly associated with endocrine and metabolic disorders, 
specially Diabetes Mellitus. This is correlated with fasting blood glucose, glycated 
haemoglobin, albumin excretion and the duration of diabetes [28]. 
 














Redistribution of magnesium 
- Refeeding and insulin therapy 
- Correction of acidosis 
- Massive blood transfusion 
Renal disease 
- Dialysis 
- Inherited disorders 
Gastrointestinal causes  
- Reduce intake 
- Mg free intravenous fluids  
- Dietary deficiency  
- Reduced absorption  
Endocrine causes  
-  Hypercalcaemia 
- Hyperthyroidism  
- Hyperaldosteronism 
Renal loss 
-  Reduced sodium reabsorption  
- Saline infusion  
Diabetes Mellitus 
Alcoholism 
Drugs   
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The hypermagnesemia is rarer than hypomagnesemia. Patients with kidney 
failure are especially susceptible to hypermagnesemia because their ability to clear 
magnesium from their bodies is impaired when administered as stated in the previous 
sentence. When serum magnesium concentrations are higher than 4.1 to 5.0 mmol/L can 
cause vomiting, hypotension and cardiac arrest. Causes of hypermagnesemia and 
magnesium deficiency are listed in the Table 1.5. Clinical symptoms of high 
magnesium deficiency, such as hypocalcemia, neuromuscular hyperactivity, and cardiac 
arrhythmias, should be assessed in conjunction with the results of these tests in making 
a final diagnosis. It is important to analyse the patient's history before stating that the 
result shows abnormal magnesium values as these determinations may be interfered 
with by the presence of certain substances (e.g. thiocyanates in tobacco smokers) [24].  
 













According to some studies, high plasma and cellular magnesium concentration 
may associate with the development of malignant tumors. Plasma and saliva magnesium 
concentrations were compared in healthy patients and patients diagnosed with parotid 
gland tumors, in which it was concluded that magnesium concentrations were higher in 





Redistribution of magnesium 




Antacids, Cathartics, Swallowing salt water 
- Rectal (Purgation) 
- Parenteral 
- Urethral irrigation 
 
Renal loss 
- Reduced sodium reabsorption 
- Saline infusion 
Renal failure 
- Chronic renal failure 
- Acute renal failure 
 
Others 
- Lithium therapy 
- Familial hypocalciuric 
hypercalcaemia 




1.3. Microfluidic Paper-based Analytical Devices (µPAD) 
Frequently used methodologies for prevention and diagnosis, capable of 
evaluating and determining compounds in different sample types, generally require high 
analytical technology, specific facilities and qualified professionals. However, 
according to the World Health Organization, diagnostic devices must ensure particular 
characteristics, such as affordable, easy-to-use, fast, equipment non-specific, robust and 
user-friendly [31]. Thus, in recent years, to break new ground in research in areas such 
as chemistry, genetics, molecular biology and other research areas, there has been a 
great interest in the development of microfluidic devices. These devices allow for 
microscale laboratory operations.  Use low-cost miniaturized equipment, small amounts 
of sample volume, which has become quite beneficial if the amount of sample to be 
used is from biological samples [32]. 
The concept of paper-based analytical microfluidic devices (µPAD) was 
invented and described by a research group from Harvard University in 2007 [33]. This 
group presented the filter paper as an alternative to developing microfluidic devices to 
use them in clinical diagnoses. They demonstrate the capability of the simultaneous 
detection of glucose and protein in the urine. The microfluidic device is represented in 
Figure 1.3. The glucose assay is based on the enzymatic oxidation of iodide to iodine 
(presence of glucose – colour change to brown). The protein assay is based on the 








Figure 1.8 - Chromatography paper patterned with photoresist. A) The darker lines are cured 
photoresist; the lighter areas are unexposed paper. B) Complete assays after spotting the reagents. C) 
Negative control for glucose (left) and protein (right) by using an a artificial urine solution. D) Positive 
assay for glucose (left) and protein (right) by using a solution that contained glucose and BSA in an 












The microfluidic devices consisted of two distinct zones: the hydrophilic zone 
(paper), where the flow movement occurs and the reaction between analytes and 
reagents, and the hydrophobic zone, which delimits the paper for the flow to remain 
only in this zone. The µPADs, when compared to conventional analytical microfluidic 
devices made from silicone, glass or polymers as a substrate, are much more affordable 
as they only use paper as a substrate. They also allow performing bioassays faster and 
cheaper [32], together with small size, lightweight, portable devices with low 
manufacturing costs. The µPADs can be handy tools when measurements need to be 
performed in less industrialized areas or even in developing countries where the 
analytical and medical infrastructure is limited, allowing for low reagent and analyte 
consumption [34].  
Since then, many researchers have used these devices as convenient tools for the 
detection and determination of many organic and inorganic compounds, offering 
analytical skills that can revolutionize the pharmaceutical and drug industry [32]. 
 
1.3.1. Advantages of using filter paper 
The option to use paper in microfluidic devices was based on the fact that the 
paper consists of cellulose fibres that act as capillaries, absorbing the solutions, making 
this transport passive, without the need for active pumping. The absorption rate depends 
on the size of the capillaries, the paper characteristics and the environment (e.g. 
temperature). The cellulose matrix can also act as a sample filter or to perform 
chromatographic separations. As the paper is available with different pore sizes, it is 
possible to separate suspended solids in the samples or to remove individual 
constituents present in the samples (e.g. proteins) [35]. Besides, the paper is an 
abundant and inexpensive raw material available everywhere.  
 Given that paper is a widely used material as a chemical platform, microfluidic 
devices can take advantage of existing techniques. This material also has the advantage 
of being available in a wide range of thicknesses, being easy to use, store and transport. 
Another advantage of using paper is that it is flammable and therefore, devices can be 
disposed of by incineration quite quickly and safely. The paper, as it is usually white, 
allows better visualization of the colorimetric reaction and its surface can be chemically 
modified [31].  
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1.3.2. µPAD fabrication techniques 
 Microfluidic devices are fabricated by moulding channels into glass, silicone, 
polymers or plastics. The µPAD design consists of patterning sheets of paper into 
hydrophilic channels (paper) bounded by hydrophobic barriers, to avoid leaks and keep 
the solution applied to the paper channels.  
The µPADs can be fabricated by using 2D (with one layer of paper) or 3D (more 
than one layer of paper) methods, to transport fluids/samples horizontally or vertically 
through the channels, depending on the complexity of the technique. The development 
of 3D microfluidic devices offers more functionality than 2D devices, as it allows fluid 
to be transported both vertically and laterally from a single inlet to numerous detection 
zones. Besides, µPAD 3D has the advantage that the flow velocity is higher because its 
length in the z-direction is shorter than in the x - y plane. When the device has two or 
more layers, it allows incorporating other characteristics to the method. For example, it 
is possible to combine different types of filter papers into one device. The use of 
different papers may aim to retain certain compounds (e.g. proteins) along the flow or, 
as the layers absorb the sample, may react with specific reagents before reaching the 
µPAD detection zone [4] [36]. 
There are several fabrication techniques available to pattern the channels of 
µPAD (Figure 1.4), for example, photolithography, wax printing (most commonly used 
when manufacturing number of devices >100), inkjet etching and printing, paper cutting 
and shaping, flexographic printing, plasma treatment, laser treatment, wet etching and 
screen-printing [37]. Some of these methods are physical processes (e.g. plotting); while 
some are chemical processes (e.g. plasma treatment) and other are environmentally-
friendly processes (e.g. wax printing). Some methods require use of toxic substances 


























Figure 1.9 - µPAD devices fabricated by (I) stamping method (II) inkjet printing (III) paper cutting (IV) 
wax printing 2D (V) photolithography (VI) screen-printed 3D. Figure adapted from [37]. 
 
1.3.3. Detection methods and quantitative image processing  
Using µPADs, it is possible to get qualitative (visible to the naked eye - higher 
or lower colour intensity) or quantitative (using analysis software) colorimetric 
analyses. The various detection methods used for microfluidic paper-based analytical 
devices are: colorimetric, luminescence, electrochemical and photoelectrochemical 
detection (Figure 1.5) [37]. 
The colorimetric detection is usually the most commonly used method in µPAD.  
Colorimetry includes visual, photometric and reflectometric detection. Quantitative 
colorimetric detection of analytes using µPADs is possible by reflectance detection 
when the intensity of the color that develops in the test zones is a function of the 
concentration of the analyte. Reflectance detection is based on the measurement of the 
light reflected off the surface of the test zone [31]. The respective device detection 
zones are scanned to the computer using a flatbed scanner, camera or mobile phone, 
depending on the image quality and lighting conditions [38]. After obtaining a high-
resolution image of the test zone, the next step is to measure the average colour 
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Photoshop). The software selects specific colour tones of the reaction products, and 
converts these values to RGB format. Then, the filter corresponding to the 
complementary colour of the reaction is applied to obtain higher sensitivity and contrast 
of the test zone. [4][38] The two advantages of µPADs are their portability and ease of 
use [33].  
Another detection method is luminescence, which includes fluorescence, 
chemiluminescence and electrogenerated chemiluminescence. These methods are 
generally more sensitive than photometry, however, require specific and more 
expensive equipment (e.g. fluorimeter). Electrochemical detection techniques can be 
used for µPADs as they are often referred to as "paper-based electrochemical devices". 
However, this technique requires a more complex methodology compared to the 
aforementioned methods due to the implementation of the electrodes on paper. Other 
technique is photoelectrochemical detection. In this method, the analytical signal is 
derived from the effect of light-induced photocurrent of an analyte interacting with a 
semiconductor electrode surface [37]. The method may be chosen according to the time 









Figure 1.10 - Detection methods used in µPADs: (I) Colorimetric (II) Fluorescence (III) Electrochemical 





1.3.4. µPADs applications platforms 
The main application of microfluidic devices is to provide fast, easy and low-
cost analytical platforms for assays, qualitative, semi-quantitative or quantitative, to be 
implemented in the diagnostic routine at an affordable price and environmentally 
friendly. There is a wide range of practical applications in many fields of research for 
which these devices can be implemented. Some of these areas are: the biochemical, 
immunological and molecular detections [39]. 
Biochemical detection may choose when in the microfluidic device (paper) 
specific reactions occur. Namely, chemical reactions (e.g. acid-alkali reaction), 
precipitation reactions or enzymatic reactions occur. In this type of reaction, the 
compound to be evaluated forms complexes with a specific reagent [40]. Exist some 
examples of biochemical reactions, such as determination of H2O2, Cd or Pb and urine 
acid.  
Immunological detection is a method that uses immunoassay techniques for a 
variety of practical applications, namely, Escherichia  coli O157:H7, Rabbit IgG and 
red blood cells agglutination. This kind of method is mainly used to detect humoral 
antibodies or antigenic substances (e.g. antigen-antibody reaction) [41]. Another 
example for applications of these devices, using immunological detection, is to separate 
blood plasma from whole blood [42]. 
In the case of molecular detection, the device is applied to detect specific nucleic 
acid hybridization sequences. Some examples of these applications are: tuberculosis 
diagnosis, target-ssDNA, ATP and Benzo[a]-pyrene (target DNA) [39]. 
In addition to the detection methods mentioned above, various types of 
procedures have been presented using paper microfluidic devices that provide new 
platforms for disease diagnosis. A colorimetric method for glucose determination, mass 
spectrometry for the determination of acetylcholine hydrolysis and potentiometric 
methods for determination of metal ions are examples of these methods [39]. 
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1.4. Objectives  
The aim of this work was to develop a simple, fast and effective microfluidic 
paper-based analytical device for magnesium determination in saliva, as an alternative 
non-invasive analysis. Small volumes of sample solutions should be introduced into one 
µPAD directly, occurring a colour reaction for colorimetric analysis.  
The paper-based microfluidic device to be produced should have the potential to 
be used as a diagnostic tool to assess patient’s risk for developing magnesium-
associated diseases (e.g. parotid gland tumor).  
For this purpose, several studies were carried out, namely:   
- The reagent for the reaction with magnesium was ; 
- Test the reaction on paper (using µPAD);  
- Optimize the microfluidic device (number of layers, filter papers, reagent 
and sample volumes);  
- Analyse possible interferences in magnesium determination;  
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2. MATERIALS AND METHODS 
 
2.1. Reagents and solutions  
All solutions were prepared with analytical grade chemicals and Milli-Qâ Water 
(Resistivity > 18 MΩ•cm, Millipore, Bedford, MA, USA).   
The reagent solution was obtained daily by dissolving 0.5 g of eriochrome 
cyanine (Sigma) in 1 mL of 8 M nitric acid in a 100 mL standard flask, adding 0.8 g of 
sodium chloride and 0.8 g of ammonium nitrate, and diluting to the mark with 
approximately 100 mL of water to final concentration of 0.01 M [43]. 
The buffer solution with pH 10.2 was prepared by dissolving 0.675 g of 
ammonium chloride (Merck) with 6 mL of concentrated ammonium hydroxide (Merck) 
(d = 0.900) and dilute it with water to 100 mL [44]. 
Artificial saliva solution was prepared by dissolving 2250 mg of potassium 
chloride (Merck), 544 mg of KH2PO4 (Merck) and 4775 mg of C8H18N2O4S (HEPES) 
(Sigma) in a 1 L standard flask of water. From this solution were withdrawn 250 mL for 
diluting 675 mg of BSA (Bovine Serum Albumin) [45]. 
Magnesium stock solution of 2.0 mM was prepared by dissolving 19.5 mg of 
magnesium chloride (Sigma) in 100 mL of water. Subsequently, from this solution, a 
dilution for 0.412 mM of magnesium was prepared. Magnesium working standards in 
the range of 0.082-0.247 mM were weekly prepared from the stock solution with the 




2.2. Microfluidic Paper-Based Analytical Device Assembly  
Using a cutter, Whatman 50 and Whatman 1 filter papers were cut into small 95 
mm diameter discs. For the assembly of the µPAD, 50 discs of Whatman 50 and 100 
discs of Whatman 1 filter paper were needed. To ensure the correct alignment with 
effective separation between the hydrophilic and hydrophobic zones, plastic pouches 
was used, in which 24 holes were cut, on one side of the pouch. Each µPAD consists of 
4 rows and 6 columns of 3 layers discs.  
The first layer contains the reagent Whatman 50 filter papers, the second layer 
includes the buffered discs (Whatman 1 filter paper) and finally a third layer consisting 
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of discs without the addition of compounds (Whatman 1). All discs were aligned so that 
all layers were overlapped (Fig. 2.1B) and distributed into the plastic pouch. After that, 
the lamination process takes place (Fellowes L125), creating a hydrophobic zone 
(plastic pouch) and a hydrophilic region (paper discs). 
 
 
2.3. Reaction and data analysis  
To Whatman 50 filter paper discs add 10 µL eriochrome cyanine reagent and 
oven dry at 50 °C for 10 minutes (Fig. 2.1A). Only to fifty Whatman 1 filters paper 
discs add 5 µL of buffer and allow drying at room temperature (T @ 25° Celsius) for 10 
minutes. For the determination of magnesium concentration, 15 µL of a sample or 
standard was deposited into the sample hole of the µPAD and, approximately 5 minutes 
has waited to covered sample holes with masking tape. After the predetermined duration 
of the colour development time, the detection zone was scanned using a flatbed scanner 
(Canon LIDE 120) to obtain the intensity readings (Fig. 2.1C).  
After obtaining a high-resolution image of the µPAD detection zone, Image J 
software was used to measure the colour intensity for the centre of each detection zone 
(hydrophilic regions) (Fig. 2.1D). The red, green and blue (RGB) colour intensity 
profile plots were obtained for a 3 mm in diameter circle in the centre of each detection 
zone. The highest sensitivity was obtained using the blue filter. 
After that, the data was imported into Excel (Microsoft Office Excel, version 
16.16.4) to be organized and for subsequent analysis (Fig. 2.1E). The average of colour 
intensity for each detection zone was subsequently converted to absorbance as proposed 
by Beer-Lambert law: A = 𝐥𝐨𝐠𝟏𝟎 &
𝑰𝟎
𝑰
(. With this formula, the absorbance value 
corresponding to each concentration was obtained by relating the average intensity of 
the blanks (Io) with the average intensity of each standard solution (I). By measuring the 
colour intensity in the detection zone, it is possible to calculate the concentration of the 


















Figure 2.4 - Schematic representation of the determination of magnesium using the developed µPAD; (A) 
Addition of reagent and buffer solution, (B) Discs alignment and µPAD plasticization, (C) Reaction time 











2.4. Batch study procedure  
For the studies carried out in classical procedure, batch studies, the methodology 










Figure 2.5 - Scheme of the batch study methodology for the Titan Yellow (A) and PAR (B) reagents. 
 
 
2.5. Mimic procedure for sample collection  
The filtration process methodology can be observed in Figure 2.3.  
 
 
Figure 2.6 - Filtration process of standard Mg solutions. 
A B 
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RESULTS AND DISCUSSION  
 
3.1. Reagents selection – batch study  
First, to develop this device, it was necessary to study the best reagent that 
determines magnesium ions in salivary samples. As µPADs are devices made of filter 
paper discs, the reagent chosen for this reaction had to meet certain conditions, like the 
reaction between the analyte and the reagent had to be direct (no precipitation) and 
colorimetric.   
Thus, there were various reagents capable of determining the analyte under the 
conditions mentioned above: titan yellow, eriochrome black T, calmagite, 4- (2-
Pyridylazo) resorcinol (PAR), 8-hydroxyquinoline, eriochrome cyanine, o-
cresolphthalein, or alizarin S [46]. Of all reagents listed, only those available in the 
laboratory were prepared, namely, titan yellow, eriochrome black T, PAR and 
eriochrome cyanine. The methodology for the preparation of each reagent and some of 
the characteristics are described in Annex I – Table I1.  
Initially, an intermediate standard solution of 0.82 mmol/L Mg2+ was used. 
Subsequently, from this solution, magnesium standards in the range of 0.016 - 0.082 
mmol/L were prepared. This preliminary batch study aimed to analyse the reaction of 
each reagent with the standard solutions, measuring the absorbance values through the 
spectrophotometer, to subsequently, relate these values to the analyte concentrations in 
a calibration curve. 
 
3.1.1. Batch study results of aqueous solutions  
The first reagents to be tested were titan yellow and PAR, both were used for 
metal ion determinations as they form water-soluble complexes between the reagent and 
the analyte, with high molar absorptive (ca. 104). However, Titan Yellow and PAR are 
not specific only for the determination of magnesium ion (Section 2.4. Figure 2.2) 
Then, the calibration curve of each reagent was established, relating the absorbance 
values and the magnesium concentrations (Anexo I - Fig. I1). After observing the graph, 
it concluded that neither reagent could determine magnesium ions, within the stipulated 
concentration range. One possible reason why the reagents did not detect the analyte 




Then, the eriochrome black T reagent was tested. This reagent is a 
complexometric indicator that is used in the water hardness determination process. In its 
protonated form, eriochrome black T is blue. It turns red/pink when it forms a complex 
with magnesium or other metals ions [44]. 
For this study, a 1 M solution of eriochrome Black T and the same procedure as 
for previous reagents was used, replacing only the reagent and decreasing the volume of 
standard solutions to approximately 0.5 mL, using a Pasteur pipette (14 drops). Then, 
the absorbance values calculated and the calibration curve established. However, after 
observing the results, it was concluded that the curve did not show the expected 
linearity and sensitivity. This may have been related to the fact that the reagent is very 
high in concentration (very saturated in colour) and so high blank values were observed. 
As the 1 M solution of eriochrome black T was very concentrated, it was 
decided to dilute it to 0.1 M. Batch studies was performed again using the same 
methodology and the reagent volume was studied in the range of 0.2 – 1.0 mL (Annex I 
- Table I2). Analysing the results, it was possible to conclude that with the increase of 
the reagent volume, both the sensitivity and the correlation coefficient decreased. Thus, 
the smaller the volume of eriochrome black T, the better the parameters for the reaction 
calibration curve. Then, as it was chosen to use 0.2 mL of reagent, it was necessary to 
study the volumes of the standard solutions again (Annex I - Table I3). The calibration 
curve for two different volumes (2 and 3 mL) was established. After observing the 
results, it was decided to use 2 mL of standard solution because the sensitivity and the 
correlation coefficient are slightly higher.  
 
Finally, the eriochrome cyanine reagent was tested — this reagent has been 
used as a chromogenic reagent for a determination of many metal ions. The 
methodology used to analyse the reaction between this reagent and magnesium was 
similar to the methods of previous reagents. 
First, different volumes of eriochrome cyanine (0.5 and 1.0 mL) were compared 
in batch, in which for each test tubes 2 mL of standard solution and 1 mL of buffer 
solution were added. After establishing the calibration curve for both reactions (Annex I 
– Table I4), it concluded that the best volume would be 0.5 mL since because the 
sensitivity and the correlation coefficient was higher. Then, batch tests again performed, 
but to study different volumes of standard solution (1, 2 or 3 mL), keeping the 0.5 mL 
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of reagent and 1.0 mL of buffer solution (Annex I - Table I4). According to the results, 
1 mL of standard solution was chosen to obtain a calibration curve with high sensitivity 
and linearity. As a smaller sample/standard volume was chosen, it was considered 
necessary to re-evaluate the reagent volume and to verify if there were significant 
changes in the evaluated parameters. The reagent volume was studied in the range of 
0.2 – 1.0 mL. The absorbance values were measured, and the calibration curves 
established (Annex I - Fig. I2) relating the absorbance to the magnesium concentrations 
for the different reagent volumes. Comparing the calibration curves, it concluded that 
the ideal volume was 0.2 mL of eriochrome cyanine because of the smaller the reagent 
volume, the higher the sensitivity and, simultaneously, the correlation coefficient. 
 
After research on articles related to saliva morphology, the expected magnesium 
concentration in salivary samples known: [Mg2+] = 0.2 mmol/L. Thus, new standard 
solutions were prepared in the concentration ranges from 0.041 to 0.33 mmol/L. Batch 
tests were again performed with the new standard solutions, but only with the 
eriochrome black T and eriochrome cyanine reagents. By changing the Mg 
concentration range, different reagent and standard volumes were retested to optimize 
the reaction. 
In the case of reaction with eriochrome black T, 1 mL of buffer solution, 2.0 mL 
of 0.1 M reagent, and two different volumes of standard solution, 2 and 3 mL, were 
added to the test tubes. Subsequently, the absorbance values were measured, and the 
calibration curves established, as can be seen in (Annex I - Table I5). As concluded 
earlier, the smaller the volume of the standard solution, the higher the sensitivity and 
linearity of the curve. Thus, it was decided to use 2 mL of the standard solution.  
To study the reaction with the eriochrome cyanine, 1 mL standard solution, 1 
mL buffer solution, and different reagent volumes (0.20 – 0.75 mL) were added to the 
test tubes. Then absorbance values were measured, and calibration curves were 
established for each volume (Annex I - Fig. I3). Each sensitivity and correlation 
coefficient of each curve were analysed and compared, and the 0.25 mL reagent volume 
was chosen. The 0.20 mL reagent volume option was excluded because the respective 
calibration curve had a lower correlation coefficient compared to the selected volume 
calibration curve.  
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3.1.2. Matrix influence assessment   
Standard solutions were prepared in synthetic saliva matrix, with the same 
concentration range of  Mg2+ (0.016 to 0.263 mmol/L). These standards were prepared 
by diluting the 2.0 mM stock solution of magnesium. Initially, as a preliminary study, it 
was decided to develop two different types of standard solutions: standards made in 
synthetic saliva with BSA protein and standards without BSA protein. For these batch 
tests, only the reactions between the eriochrome cyanine and eriochrome black T 
reagents with the magnesium analyte were evaluated. The methodology used was the 
same in which 1 mL of standard solution, 1 mL of buffer solution and 0.25 mL of 
reagent added to the different test tubes for the eriochrome cyanine. In the case of the 
reaction with the eriochrome black T, 2 mL of standard solution, 1 mL of buffer 
solution and 0.20 mL of reagent added. The absorbance values were calculated, and the 
various calibration curves established, as shown in Table 3.1.  
 
Table 3.3 - Correlation of absorbance with Mg concentration  for different reagents. 




Yes A = 0.399 [Mg2+] – 0.008 0.989 
No A = 0.531 [Mg2+] + 0.096 0.931 
Eriochrome black T 
Yes A = 0.183 [Mg2+] + 0.004 0.987 
No A = 0.115 [Mg2+] + 0.047 0.387 
 
 After observing the results, it was concluded that both reagents could determine 
magnesium ions in the standard solutions made with synthetic saliva, except the 
reaction between eriochrome black T with those without BSA protein. However, 
eriochrome cyanine was the reagent that displayed a higher sensitivity and correlation 
coefficient. Thus, the eriochrome cyanine reagent was chosen as the reagent for the 
determination of magnesium.  
 In addition to the reagent study, different pH values were also batch tested for 
the buffer solution, namely 10, 11 and 12. The results can be analysed in Annex I – Fig. 
I4, which concluded that the best option was to use the pH 10 buffer, as the sensitivity 
was similar among all, thus avoiding the presence of higher amounts of hydroxide in the 
standard solutions.   
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3.2. Microfluidic Paper-based Analytical Devices - Design  
 In this work, for all tests performed, a univariate statistical analysis was used, 
that is, several variables, chemical and physical, were studied separately. With this type 
of analysis, some tests may need to be retest due to changes in certain interconnected 
variables.   
 
3.2.1. Preliminary studies  
Initially, we decided to perform some preliminary studies in which µPAD 
developed for eriochrome black T and eriochrome cyanine reagents, to evaluate the 
reactions previously studied on paper. In these assays, the option of using eriochrome 
black T was discarded as no staining could be observed in the detection zone. As 
mentioned earlier, the use of these devices implies that there is a colorimetric reaction to 
measure the colour intensity values of each disc subsequently. Thus, the subsequent 
studies were performed using only the eriochrome cyanine as the reaction reagent. So 
far, to calculate the absorbance values of the standard solutions, a spectrophotometer 
has been used.  
However, in the µPAD, quantitative colorimetric detection was possible by 
calculating the absorbance based on the intensity of the colour developed in the test 
zone. To measure colour intensity, Image J software was used and the RGB model was 
applied to obtain the highest sensitivity. The same calibration curve was compared 
using two different colour filters (Fig. 3.1A). According to the colours theory, the 
combination of two colours that are on opposite sides of the colour wheel (Fig. 3.1B) 
allows for higher contrast and brightness. Although the eriochrome cyanine colour is 
orange, when it reacts with the magnesium ions, the colour of the reaction turns red to 
orange. After analysis of the results, we chose to use the blue filter because the 







Figure 3.1 - Colour wheel (A) and filter colour study (B) to Mg determination.  
A B 
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The next studies were performed with standard solutions prepared in water, with 
the same concentration range of Mg2+.  
The first step was to develop µPAD with only one layer of Whatman 42 filter 
paper discs. The device having only one layer implied that both buffer and reagent were 
added to the same disc. Previous batch studies only proved that it was possible to obtain 
a calibration curve that relates the absorbance values to the Mg2+ concentrations by 
separately adding the reaction integrating solutions. As the objective was to test the 
µPAD with only one layer, new batch studies were performed in which a pre-made 
solution with the reagent and buffer mixed was used. Comparing the calibration curves 
of each case (Table 3.2), it concluded that both alternatives could determine Mg2+ with 
high sensitivity.  
Then, the previous reaction was tested on paper. To this end, 10 µL of the "mix" 
solution was added to each disc and allowed to dry in the oven at 50° C for 10 minutes. 
Subsequently, the discs were lined up in the plastic pouches and, after the device was 
ready for use, 8 µL of the several standard solutions were added. However, after drying 
of the sample, no gradual colour difference was observed as the Mg2+ concentration 
increased.  In this case, most discs showed colours that didn't match the reagent used 
(Figure 3.2). This could be related to possible contamination, since the paper disc was in 
direct contact with air, or simply because the reaction occurred only in one layer.  
 
 
Figure 3.2 - Scan the µPAD detection zone with one layer, from standard solutions with the highest Mg 
concentration (P4, P5 and P6). 
 
 43 
So, the construction of µPAD was studied with two layers of Whatman 42 filter 
paper. In this study, it was decided to construct the device in two different ways: one 
µPAD with the reagent and buffer solution in the first layer and the second layer empty, 
and another µPAD with the reagent in the first layer and the buffer solution in the 
second layer. Mounting conditions and volumes added were the same for both devices. 
According to the results obtained (Table 3.2), it was decided to choose the assembly 
that uses the reagent and the buffer solution in different layers, because the sensitivity 
and the correlation coefficient were higher. 
 
Table 3.4 - Features of calibration curves in batch and µPAD tests. 




All solutions added separately A = 0.648 [Mg2+] + 0.023 0.998 
“Mixing” solution + sample A = 0.413 [Mg2+] + 0.019 0.989 
µPAD 
All solutions in different layers A = 0.101 [Mg2+] + 0.011 0.996 
All solutions in the same layer A = 0.054 [Mg2+] + 0.003 0.948 
 
 
3.2.2. Buffer layer study  
Maintaining the µPAD construction conditions with two layers of Whatman 42 
filter paper, in which the reagent is in the first layer and the buffer solution in the 
second layer, it was decided to study different volumes for the buffer solution. For this, 
5 µL of reagent added to all discs of the first layer and 5 - 15 µL of buffer solution were 
studied. With all µPAD ready for use, 10 µL of standard/sample added to the holes in 
the plastic bags. Calibration curves (absorbance vs Mg concentration) established for 
each volume at different scanning times and then the sensitivity of the respective 
volumes tested were compared (Figure 3.3). Of all volumes, 5 µL of buffer solution 




Figure 3.3 - Comparison of the calibration curve slope, sensitivity, using different volumes of buffer 
solution; Error bars represent 10% deviation. 
To increase the rate of reaction flow, it was decided to try Whatman 1 (Particle 
Retention = 11 µm) on the second layer, since the pore sizes of this paper type were 
relatively larger than Whatman 42 (Particle Retention = 2.5 µm). Later, after adding 10 
µl of standard solutions, it was found that the sample drying time was shorter when 
filter paper Whatman 1 was used in the second layer (Drying time Whatman 42 = 5 minutes; 
Drying time Whatman 1 = 2 minutes). Comparing the method sensitivities for both cases 
(Fig. 3.4), it was possible to conclude that Whatman 1 filter paper would be the best 
option, because the sensitivity did not vary significantly over time, the opposite of 
Whatman 42 paper decreases. Besides, it was an advantage that sensitivity did not vary 
significantly over time as it gives the technician a longer time to scan µPAD after 
adding the sample. 
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Figure 3.4 - Comparison of the calibration curve slope, sensitivity, for Whatman 42 and Whatman 1 filter 
paper; Error bars represent 10% deviation. 
 
3.2.3. Reagent layer study  
After choosing the volume and paper for the buffer layer, it was necessary to 
optimize the reagent layer (detection zone). The reagent volume was studied in the 
range of 5-15 µL, keeping 5 µL of buffer solution and 10 µL of standard or sample 
solution. According to the results obtained (Figure 3.5), by adding 10 µL of reagent, the 
reaction sensitivity is much higher. The 15 µL of reagent was excluded because it took 
about 30 minutes to dry.   
 
Figure 3.5 - Comparison of the calibration curve slope, sensitivity with different reagent volumes; Error 
bars represent 10% deviation. 
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Subsequently, different filter papers for the reagent layer were studied. Since 
this layer was the device's respective detection zone, it was essential to evaluate the type 
of paper that best suits you. For this, three types of paper with very similar 
characteristics assessed, namely, Whatman 42, Whatman 50 and Whatman 1. The 
characteristics of different filter papers can be observed in Annex II – Table II6.  To 
develop µPAD, 5 µL of buffer solution added to the second layer discs and, at the end, 
15 µL of standard solution/sample added to the holes in the plastic pouches. On all 
devices, the sample drops took approximately 15 minutes to dry completely, performing 
the first scan 20 minutes after addition. According to the results obtained (Fig. 3.6), the 
Whatman 50 paper was chosen because it presented a very high sensitivity. Comparing 
Whatman 50 filter paper with the others, it had approximately twice the sensitivity 
value.  
 
Figure 3.6 - Comparison of the calibration curve slope, sensitivity, for Whatman 42, Whatman 50 and 
Whatman 5  filter papers in the reagent layer; Error bars represent 10% deviation. 
 
 
3.2.4. Sample/standard solution study   
All studies associated with the optimization of the standard solution or sample in 
µPAD used the standards prepared with synthetic saliva matrix with BSA protein. All 
standards had the same concentration range of Mg2+.   
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The first sample study was performed when the µPAD consisted of two layers of 
Whatman 50 (reagent layer) and Whatman 1 (buffer layer) filter papers. In this study, 
10 - 20 µL of the standard solution tested. After the addition of the sample, it concluded 
that the larger the volume added, the longer the drying time (T 10µL @ 5 min; T 15µL @ 15 
min; T 20µL @ 40 min). Since one of the objectives of this work was to develop a device 
that would benefit from rapid data analysis, the option of using 20 µL immediately 
excluded because of the long drying time of the sample. Thus, the first scans were 
performed at different times, namely 10 and 20 minutes after the addition of the sample. 
Through the analysis of the results (Fig. 3.7), it was decided to use 15 µL of 













Figure 3.7 - Comparison of the calibration curve slope, sensitivity,  for different standard volumes; Error 
bars represent 10% deviation. 
 
 To reduce potential µPAD contamination and protect the operator from direct 
contact with biological samples, adhesive tape was used to cover all holes in the plastic 
pouch after the sample/standards absorption. In order to ensure that this would not 
affect the detection µPADs with and without adhesive tape were compared (Fig. 3.8). 
According to the results obtained, we chose to implement in the design of µPAD the use 
of adhesive tape, since there were no significant variations in the parameters previously 
evaluated.   




Figure 3.8 - Comparison of the calibration curve slope, sensitivity, for adhesive tape study; Error bars 
represent 10% deviation. 
 
 
The influence of the most operational parameters studied to develop an efficient  
µPAD and the respective optimal choices were summarised in  Table 3.3. 
 





3.2.5. Reaction time  
Reaction time is the time interval from sample placement to µPAD detection 
zone reading. The sample drying time was approximately 15 minutes using 15 µL of 
sample/standard, which implies that the first scan of the detection zone can only 
perform 20 minutes after the addition of the sample. Therefore, to reduce reaction time, 
it was considered to study a three-layer µPAD design by introducing a third layer with 
Whatman 1 filter papers. In addition to maintaining the same model, the volumes of 
reagent used, buffer as well as sample were also equal. 
Calibration curves (0.041 – 0.245 mM of Mg standards) were performed for the 
two possible µPAD assemblies: two and three layers (Fig. 3.9).  
The first difference between both devices was noticeable at the time the sample 
added as the drying time reduced from 15 minutes to approximately 2 minutes. The 
main advantage of obtaining a reduced drying time was that it was possible to perform 
the first scan just 5 minutes after the addition of the sample. Comparing the two models, 
it observed that there was no significant variation in the sensitivity of both reactions to 
determine magnesium. By introducing a third layer to the µPAD, the buffer solution 
layer was no longer in direct contact with air. Looking ahead, when developing a three-
layer µPAD, it may also serve as a filter to retain specific proteins that are larger than 
the pore size of Whatman 1 paper, or other types of compounds present in salivary 
samples.    
 
Figure 3.9 - Comparison of the sensitivity of two and three layers µPAD magnesium determination; 
Error bars represent 5% deviation. 
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Thus, we chose to implement the design with three layers, since the advantages 
mentioned above do not interfere with the optimized parameters and do not alter the 
development objective of this device.  
Another alternative, to try to shorten the reaction time, was to use a hair dryer 
directly into the holes of the device. Thus, the hair dryer was used, at minimum 
temperature and reduced air velocity, for approximately 10 minutes. However, while 
analysing the results, a high dispersion in the colour intensity between discs within the 
same Mg2+ standard was observed (Annex III – Fig. III7). This can be explained due to 





3.3. Microfluidic Paper-based Analytical Device – Features  
The main features of the developed device were summarized in Table 3.4.  






A = slope ± SD [Mg2+] + 
















0.082 – 0.247 A = 0.206 ± 0.005 [Mg2+] + 0.011 ± 0.001 0.062 0.081 1.18 
ERCR = 0.043 
NH4Cl = 1.62 
NH4OH = 13.0   
120 
a n=5 
b per calibration curve 
 
Under the optimum conditions, the proposed µPAD method was characterized 
by linear calibration ranges for magnesium concentrations 0.082 – 0.247 mmol/L. The 
calibration presented was the result of five calibration curves performed on the same 
day, all under the same design conditions. After calculating the limits, the standard of 
0.041 mM was excluded. 
The limit of detection (LOD) and the limit of quantification (LOQ), were 
calculated according to IUPAC [47][48][49], expressed as LOD = 3´ Standard 
deviation of the calibration line/ Slope of the calibration line; LOQ = 10 ´ Standard 
deviation of the calibration line/ Slope of the calibration line. 
The precision was assessed by calculating the repeatability based upon the 
relative standard deviation (RSD) of slope of the calibration line (n = 5). The reagents 
consumption values were also calculated per calibration curve (each calibration curve 
corresponds to two µPADs). 
 The sample consumption value is the volume required for each determination, 








3.4. Interferences assessment 
 Besides optimizing the device developed and the reaction that occurs in it, it was 
also important to evaluate certain factors that may interfere with the determination of 
magnesium in salivary samples. One of the interfering elements for this reaction was the 
presence of calcium since saliva has more calcium than magnesium, and both analytes 
are alkali metals with similar physical and chemical properties. Saliva is also composed 
of various ions and proteins, which may also be interfere in the magnesium 
determination. 
Standard solutions of magnesium, calcium and both cations, with the same 
concentration range (0.082 - 0.245 mM) were prepared in synthetic saliva matrix with 
BSA protein. All standard solutions with calcium were made from dilution of an 
intermediate CaCl2 (Sigma) solution with [Ca2+] = 0.5 mM. 
 
 
3.4.1. Potential calcium interference 
For the possible interference of calcium in the determination of magnesium in 
saliva, several studies performed, namely in batch and in µPAD.  
In batch tests, calibration curves were compared (Fig. 3.10) and no differences 
were observed between the calibration curve of magnesium standard and the one with 
mixed standards.  
 
Figure 3.10 - Calibration curves of the three standard solutions in batch; Error bars represent 10% 
deviation. 
Magnesium standards 
A = 0.815 [Mg2+] + 0.009 
R2 =  0.995 
Mg + Ca standards 
A = 0.828 [Mg +Ca] + 0.022 
R2 =  0.996 
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This feature, together with the no calibration curve obtained with calcium 
standards, can be an indicator that there is no significant interference from calcium. The 
presence of calcium only appears to interfere when the concentration of is less than or 
equal to 0.041 mM (no overlapping of 10% deviation intervals). However, this standard 
was excluded from calibration curve after calculation of the LOD.   
However, as the expected Ca2+ concentration in salivary samples ranges from 1-
4 mmol/L, it was necessary to prepare a new intermediate solution with [Ca2+] = 5 mM. 
Then, new standard solutions with a concentration range of 1- 4 mmol/L were prepared.  
The first study in µPAD was performed to analyse the kinetics of calcium 
reaction with the eriochrome cyanine reagent over time. Thus, several reaction times 
were compared within 20 - 120 minutes. The slope, sensitivity, of the respective 




Figure 3.11 - Kinetics study of calcium reaction with eriochrome cyanine reagent. Error bars represent a 
10% deviation. 
 According to the results obtained, it could not be inferred that sensitivity to the 
calcium reaction varied significantly. This decision was based on the overlapping of the 
10% deviation intervals, regardless of the reaction time.    
The second study in µPAD, was to compare the calibration curve of the Mg 
standard solutions with the calibration curve of the Mg standards in the presence of 1 





Figure 3.12 - Study of the presence of 1 and 4 mM calcium in the magnesium determination; Error bars 
represent a 10% deviation. 
 Analysing the results, it inferred that the presence of 1 mM calcium (best case) 
did not significantly interfere in the determination of magnesium (overlapping of 10% 
deviation intervals). However, the presence of 4 mM calcium (worst case) interfered 
with the determination of magnesium, (no overlapping of 10% deviation intervals). 
The last µPAD study related with the potential calcium interference was to 
analyse the minimum calcium concentration that may be present in salivary samples, 
without interfering with magnesium detection. For this, the lowest concentration Mg 
standard (P1 = 0.041 mM) and the highest concentration Mg standard (P4 = 0.245 mM) 
were compared in the presence and absence of calcium, over a concentration range 0.5 - 
4.0 mM. In this study, µPADs were scanned for several reaction times, 5 - 65 minutes 
(Fig. 3.13).   
According to the results obtained, with the reaction time of 5 minutes, only the 
presence of 4 mM Ca2+ interferes with the determination of magnesium (no overlapping 
of 10% deviation intervals).  It can also be concluded that as reaction time increases, 
lower calcium concentrations already interfere with magnesium determination (e.g. with 
reaction time equal to 25 min, 2 mmol/L de Ca2+ already interferes in Mg 




A = 0.106 [Mg2+] + 0.007 
R2 =  0.998 
Mg standards + 1mM Ca2+ 
A = 0.105 [Mg2+] + 0.008 
R2 =  0.994 
Mg standards + 4mM Ca2+ 
A = 0.145 [Mg2+] + 0.015 





















Figure 3.13 - Study of calcium interference (0.5 – 4.0 mM) in the lowest concentration Mg standard (P1) 
and the highest concentration Mg standard (P4); Blue bars represent Mg standards and green bars 
represent Mg standards in the presence of Ca; Error bars represent a 10% deviation.  
 
This study also served to complement the decision to choose 5 minutes for the 
reaction time, because only 4 mM de Ca2+ (worst case) interferes with the Mg 
determination.  
  
3.4.2. Proteins interference assessment 
 All magnesium standards, for the previous studies, had been prepared from a 
stock solution of MgCl2 with 0.41 mM (prepared in water), which corresponded to a 
dilution of the matrix (synthetic saliva) of about ½. The matrix being diluted to ½, 
implies that all of its compounds also diluted equally. However, in salivary samples, the 
matrix is not diluted. So, to mimic better the saliva samples and without causing 
dilution of the matrix (synthetic saliva), new magnesium standards was prepared from a 
stock solution of MgCl2 with 2.06 mM.   
Reaction time: 5 min Reaction time: 25 min 
Reaction time: 35 min Reaction time: 65 min 
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 Simultaneously, an alternative was studied to try to retain certain proteins 
present in the synthetic saliva matrix. This study consisted of a filtration process using 
sterile gauze, describe in section 2.5 (Figure 2.3).   
Using µPADs, Mg standards prepared in diluted matrix, Mg standards prepared 
in no diluted matrix and filtered Mg standards prepared in non diluted matrix, were 
tested. The slopes of each calibration curve (sensitivity) for the different standards at 
three reaction times (5, 15 and 30 minutes) were compared (Fig. 3.14).   
 
 
Figure 3.14 - Study of proteins interferences in the determination of magnesium in salivary samples; 
Error bars represent a 10% deviation. 
According to the results obtained, the Mg standards prepared in diluted synthetic 
saliva matrix are the ones with the highest sensitivity. Mg standards prepared in 
undiluted matrix are those with lower sensitivity (decreased to about half). However, if 
the Mg standards are filtered with sterile gauze, sensitivity increases compared to 
unfiltered standards. 
It can be concluded that the sensitivity in the detection of magnesium is similar 
in the standards prepared in diluted matrix and in the filtered standards (overlapping of 
10% deviation intervals). However, this only happens for the reaction time of 5 minutes. 
With increasing reaction time there is no overlapping of 10% deviation intervals.  
This study complemented the decision to choose scan the µPAD detection zone 
at 5 minutes.  
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4. CONCLUSIONS AND FUTURE WORK 
 
The microfluidic paper-based analytical device for the magnesium determination in 
saliva was developed. The µPAD combined with the colorimetric reaction of the analyte 
and the Image J software can provide an inexpensive and easy-to-use tool for the 
quantitative detection of unknown sample concentration. Therefore, it is expected to be 
of particular interest to developing countries or in less-industrialized areas, where 
analytical infrastructure is limited. It should also be pointed out that the proposed 
method is also environmentally friendly due to the use of very small amounts of 
reagent. 
By using this device, we were able to reduce not only the volumes of the reagents, 
but also the sample quantities. Thus, the use of µPAD becomes very beneficial if the 
sample volumes are limited. It is important to emphasize that less than 120 µL of saliva 
is required for magnesium determination. 
After optimizing the various µPAD parameters, the stipulated reaction time was 5 
minutes, which means that we were able to get the results of the Mg determinations 
quite fast. The detection and quantification limits were 0.062 mM and 0.081 mM, 
respectively. Based on the results obtained, it can conclude that the proposed paper-
based method is characterized by high sensitivity, a high degree of portability and low-
cost analysis. 
Furthermore, it was concluded that the longer the reaction time, the higher the 
possibility of calcium interfering with magnesium determination. The detection zones of 
µPAD should be scanned 5 minutes after sample addition to reducing the potential 
interference. In order to avoid other possible interference (e.g. proteins present in 
saliva), it is concluded that it would be advantageous to filter the samples on sterile 
gauze, with the purpose of retaining larger compounds present in saliva. With the 
filtration process, smaller compounds (e.g. magnesium ions) move better along the 
flow.  
All these features of the paper-based method suggest that it is a potential tool for 
routine assessment of patient’s risk of oral cancer development (parotid gland tumour), 
Diabetes Mellitus or chronic renal failure. 
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However, the developed µPAD method was not fully validated, as it was not applied 
to saliva samples and the results compared to a reference procedure. This would be the 
logical continuation of this work. Additionally, there are some parameters that could be 
improved or even further studies to make this device more effective accurate in 
determining magnesium. To avoid potential calcium interference, one more component 
could be added to the µPAD design, with the aim of calcium complexing before 
reaching the detection zone and influencing Mg determination.  
It would be important test new and innovative materials to maximize system 
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Annex I –  Reagent choice in batch study  
 







0.1 M 1.8 x 104 
(λ = 520 nm) 
Reagent solution: dissolve 
0.005 g of Eriochrome Black T 
in 50 mL of ethanol 
 
Buffer solution: dissolve 0.675 
g of ammonium chloride with 6 
mL of concentrated ammonium 
hydroxide in a 100 mL of water 
[44] 
Titan 
Yellow 0.01 M 
3.4 x 104                               
(λ = 545 nm) 
Reagent solution: dissolve 0.01 
g in 100 mL of water 
 
Buffer solution: Boric acid 
(available in the lab)  
[50] 
PAR 0.1 mM 3.45 x 10
4                              
(λ = 545 nm) 
Reagent solution: dissolve 
0.0766 g of the monosodium salt 
in 100 mL of water. § 
 
Buffer solution: Boric Acid 









Cyanine 0.1 M 
5.9 x 104 
(λ = 610 nm) 
Reagent solution and Buffer 











Figure I1: Calibration curves of Titan Yellow and PAR reagent for magnesium detection. 
 
Table I2: Features of calibration curves for different reagent volumes (Eriochrome Black T) 
 
Table I3: Features of calibration curves for different standards volumes using Eriochrome 
Black T as reagent.     
  
PAR
A = - 0.7388 [Mg2+] + 0.0966
R² = 0.8223
Titan Yellow


























5 A = 0.3131 [Mg2+] - 0.0041 0.8808 0.0272 
9 A = 0.2358 [Mg2+] + 0.0012 0.8386 0.0263 
14 A = 0.2173 [Mg2+] + 0.0107 0.7517 0.0232 
19 A = 0.1085 [Mg2+] + 0.0308 0.0675 0.0201 
24 A = 0.0497 [Mg2+] + 0.0315 0.0233 0.0200 
Magnesium 
concentrations  
Volume of standard 
solutions (mL) 
Regression equation  Correlation 
coefficient 
0.016 - 0.082 mmol/L 
2 A = 0.3282 [Mg2+] + 0.0254 0.9978 
3 A = 0.3131 [Mg2+] – 0.0041 0.8808 
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Table I4: Features of calibration curves for different reagent and standards volumes using 






Figure I2: Calibration curves of different volumes of reagent (Eriochrome Cyanine) for 
magnesium determination.  
 
Table I5: Features of calibration curves for different standards volumes using Eriochrome 
Cyanine as reagent.   
Magnesium 
concentrations 





0.08 - 0.33 mmol/L 
2 A = 0.1086 [Mg2+] + 0.0195 0.9956 
3 A = 0.0827 [Mg2+] – 0.0016 0.9597 
 
 
0.2 ml of reagent
A = 3.8657 [Mg2+] + 0.1088
R² = 0.9825
0.5 ml of reagent
A = 0.3607 [Mg2+] + 0.0155
R² = 0.9565
1.0 ml of reagent



















0.2 ml 0.5 ml 1.0 ml
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Figure I3: Calibration curves of different volumes of reagent (Eriochrome Cyanine) for 




















5 drops of reagent
A = 1.1236 [Mg2+] + 0.1414
R² = 0.9541
0.25 ml of reagent
A = 0.6483 [Mg2+] + 0.0231
R² = 0.998
0.50 ml of reagent
A = 0.3776 [Mg2+] - 0.0238
R² = 0.9966
0.75 ml of reagent
















5 drops of reagent 0.25 ml of reagent
0.5 ml of reagent 0.75 ml of reagent
pH 10 
A = 1.284 [Mg2+] + 0.020 
R2 =  0.998 
pH 11 
A = 1.287 [Mg2+] + 0.065 
R2 =  0.997 
pH 12 
A = 0.1281 [Mg2+] + 0.157 
R2 =  0.995 
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Annex II –  Reagent layer study 
 
 
Table II6 – The different groups of filter paper types and their degrees of purity, hardness and 

















Annex III – Reaction time study  
 
Table III7 – Analysis of absorbance values for the reaction time study. (A) Using the hair dryer 
to dry the samples on 2 layers µPAD. (B) 3 layers µPAD.   
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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